涎腺癌

xián xiàn ái
  • Salivary gland carcinoma;carcinoma of salivary gland
涎腺癌涎腺癌
  1. 涎腺癌DNA含量的流式细胞分析及其临床病理学意义

    Flow cytometric DNA analysis of salivary gland carcinomas and clinicopathologic implications

  2. 这表明DNA倍体异常是涎腺癌的一个重要生物学特征,对于指示涎腺癌的生物学行为、指导治疗和判断预后具有一定的临床意义。

    This indicates that abnormal cellular DNA content is an important biological characteristic of salivary gland carcinomas . The relationship between DNA ploidy and prognosis was not found .

  3. 涎腺癌及涎腺正常组织MDRlmRNA表达的研究

    Expression of mdrl mRNA in normal salivary gland and its related carcinoma

  4. survivin可能通过抑制涎腺癌的细胞凋亡,对涎腺癌的发生发展起重要作用;

    Survivin possibly plays an important role in the occurrence and the development of salivary gland carcinoma .

  5. 目的:探讨阿霉素诱导人涎腺癌细胞凋亡过程中细胞游离Ca2+([Ca2+]i)和蛋白激酶C(PKC)浓度的变化特点和意义。

    Objective : To study the significance of intracellular free calcium levels ( [ Ca 2 + ] I ) and protein kinase C ( PKC ) levels in the process of human salivary gland mucoepidermoid carcinoma MEC-1 cell apoptosis induced by adriamycin .

  6. 结果:涎腺癌肉瘤临床表现常为迅速增大的颜面部肿物并伴疼痛。

    Results Initial symptoms of salivary carcinosarcoma were ache and tumidness of face .

  7. 本法对诊断口腔领面部鳞癌,涎腺癌有较高的阳性检出率,而且假阳性很低。

    Histologically , higher positive rates were found in squamous carcinoma and salivary gland adenocarcinoma .

  8. 涎腺癌肉瘤临床及病理分析

    Clinicopathological analysis of salivary carcinosarcoma

  9. 硬腭小涎腺癌的疗效评价和预后因素分析

    Effectiveness Evaluation and Prognostic Factor Analysis in Patients with Minor Salivary Gland Carcinoma of the Hard Palate

  10. 150例涎腺癌3、5、10年生存率为80.7%、69.4%、52.1%。

    The 3,5 and 10 year survival rates of these 150 patients were 80 . 7 % , 69 . 4 % . 52 . 1 % respectively .

  11. 目的通过对146例口腔癌及涎腺癌颈部淋巴组织清扫术进行临床分析,为选择合理的口腔癌及涎腺癌颈淋巴组织清扫术术式提供依据。

    Objective To provide clinical basis for selecting rational approach for neck dissection of oral carcinomas ( OC ) and salivary gland carcinomas ( SGC ) by analyzing the neck dissection of 146 cases of OC and SGC .

  12. 背景与目的:硬腭小涎腺癌由于发病率低、长期生存率较高,使评价其治疗效果及预后因素较为困难。

    BACKGROUND & OBJECTIVE : Minor salivary gland carcinoma of the hard palate is rare , and its long term survival rate is high , making it difficult to evaluate the prognostic factors and the efficacy of treatment .

  13. 术后放疗和化疗,对涎腺癌,生存率是重要的,涎腺癌复发率为27.6%,颈淋巴结转移率为9.2%。

    Postoperative radiotherapy and chemotherapy may increase the survival rate of the patients with carcinoma of salivary glands . The overall recurrent rate was 27 . 6 % , the neck lymph node metastasis rate was 9.2 % .

  14. 涎腺腺癌COX-2表达和肿瘤血管生成的研究

    Study of COX-2 expression and angiogenesis in salivary gland adenocarcinoma

  15. MVD随着VEGF和iNOS表达的增强而增加,说明两者对涎腺腺癌血管生成具有促进作用。

    The iNOS and the VEGF are associated with the angiogenesis of salivary adenocarcinoma .

  16. 目的探讨环氧合酶-2(COX-2)表达和涎腺腺癌血管生成的关系。

    Objective To explore the relationship between COX-2 expression and angiogenesis in salivary gland adenocarcinoma .

  17. 结果PCNA在涎腺腺癌中的表达阳性率为(76.12±19.24)%,表达呈异质性。

    Results The positive rates of PCNA expression in salivary glands adenocarcinoma tissue was 76.12 ± 19.24 % .

  18. 目的研究微血管密度(MVD)和血管内皮生长因子(VEGF)在涎腺腺癌中的表达,探讨其与预后关系。

    Objective To evaluate the clinical significance of microvessel density ( MVD ) and vascular endothelial growth factor ( VEGF ) expression in salivary glands adenocarcinoma .

  19. 12例涎腺导管癌临床生物学特点及预后分析

    Analysis of clinical-biological characteristics and prognosis of 12 salivary duct carcinoma

  20. 涎腺肌上皮癌6例报告

    Myoepithelial Carcinoma of Salivary Glands . A Report of 6 Cases

  21. 涎腺肌上皮癌的生物学行为及治疗

    The behaviour and treatment of myoepithelial carcinoma of salivary glands

  22. 13例涎腺腺癌的治疗与预后探讨

    Study on the Therapy and Prognosis of 13 Cases of Salivary Adenocarcinoma

  23. 涎腺导管癌

    Salivary duct carcinoma : An analysis of three cases with review of literature

  24. 涎腺导管癌临床病理和免疫组化研究

    Salivary duct carcinoma clinicopathologic and immunohistochemical study

  25. 方法:本研究对6例涎腺导管癌进行临床病理分析。

    Methods : This study was to investigate clinicopathological characteristic of 6 salivary duct carcinomas .

  26. 13例涎腺腺癌的临床分析

    Clinical Analysis for Therapy and Prognosis of Adenocarcinoma Salivary Glands : A Report of 13 Cases

  27. 目的了解涎腺腺癌发病情况、构成特点,并探讨13例涎腺腺癌的治疗方式和治疗效果,指导临床实践。

    Objective To investigate the clinical features , the operative type and therapeutic efficacy of salivary adenocarcinoma .

  28. 免疫组化研究对于判断涎腺导管癌早期局部复发、远处转移和生存率有所帮助。

    Immunohistochemical study was linked to the early local disease recurrence , distant disease metastasis and survival rates .

  29. 提要作者回顾分析最近两年所诊治的涎腺导管癌资料,讨论了临床表现,组织病理学特征和治疗方法。

    I the past two years , three cases of salivary duct carcinoma were treated and the clinical features , pathological characteristics and therapy were discussed .

  30. 结论:涎腺导管癌高度恶性,预后较差,治疗方法以局部彻底扩大切除,根治性颈清为主,术后辅以放疗和化疗。

    Salivary duct carcinoma was high-grade malignancy and prognosis was bad . Conclusions : Complete local excision with radical neck dissection and postoperative radiation therapy seemed to offer the most potential for effective treatment .

热门查询